Press Releases
November 24, 2025
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
Neutral
EIN Presswire
November 26, 2025
Cell Culture Collagen Market to Attain USD 4.19 Billion by 2034, Driven by Expanding Healthcare Applications
Indeterminate
GlobeNewswire, Inc.
January 14, 2026
Trends in Metallized Film Market 2025-2035
Indeterminate
GlobeNewswire, Inc.
November 17, 2025
Berberine API Market to Reach USD 973.13 Million by 2034, Driven by Expanding Healthcare Applications
Indeterminate
GlobeNewswire, Inc.
October 22, 2025
Iceland finds mosquitoes for first time after facing record heat
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
November 6, 2025
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
Indeterminate
GlobeNewswire, Inc.
November 12, 2025
Wound Care Centers Market to Attain USD 64.49 Billion by 2034, Driven by Rising Disease Burden and Healthcare Innovations
Indeterminate
GlobeNewswire, Inc.
November 12, 2025
Molecular Cloning Market to Attain USD 8.89 Billion by 2034, Driven by Expanding Healthcare Applications and Innovation
Indeterminate
GlobeNewswire, Inc.
November 10, 2025
Orphan Drug Market to Reach USD 621.85 Billion by 2034, Driven by Rising Rare Disease Incidence and Innovation
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
High Concentration mAb Products Market Advancing Precision Biopharmaceutical Therapeutics – Towards Healthcare
Indeterminate
GlobeNewswire, Inc.
November 5, 2025
Protein Engineering Market to Grow at 16.27% CAGR by 2034, Driven by Rising Outsourcing and Expanding Healthcare Applications
Indeterminate
GlobeNewswire, Inc.
October 29, 2025
NLP in Healthcare and Life Sciences Market Size Grows at 34.74% CAGR to Soar USD 132.34 Billion 2034
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
Why Poly-Woven Packaging Market Manufacturers are Successful
Indeterminate
GlobeNewswire, Inc.
October 6, 2025
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Investments in Colorless Polyimide Films Market for 2026
Indeterminate
GlobeNewswire, Inc.
September 22, 2025
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
Indeterminate
GlobeNewswire, Inc.
January 6, 2026
Alvotech announces planned CEO succession and leadership transition
Indeterminate
GlobeNewswire, Inc.